|
Volumn 69, Issue 14, 2012, Pages 2279-2282
|
NOX enzymes as drug targets
|
Author keywords
NADPH oxidases (NOX); NOX and disease; Peptide inhibitors; Reactive oxygen species (ROS)
|
Indexed keywords
ENZYME INHIBITOR;
REACTIVE OXYGEN METABOLITE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4;
UNCLASSIFIED DRUG;
VAS 2870;
ACUTE LUNG INJURY;
ADULT RESPIRATORY DISTRESS SYNDROME;
ALZHEIMER DISEASE;
BRAIN ISCHEMIA;
DRUG MECHANISM;
DRUG TARGETING;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
ENZYME ANALYSIS;
ENZYME INHIBITION;
EXTRACELLULAR MATRIX;
HEARING LOSS;
HUMAN;
LUNG FIBROSIS;
MOLECULAR EVOLUTION;
NEUROTOXICITY;
NONHUMAN;
PARKINSON DISEASE;
REVIEW;
SIGNAL TRANSDUCTION;
ENZYME INHIBITORS;
HUMANS;
NADPH OXIDASE;
PEPTIDES;
PROTEIN ISOFORMS;
REACTIVE OXYGEN SPECIES;
|
EID: 84864362404
PISSN: 1420682X
EISSN: 14209071
Source Type: Journal
DOI: 10.1007/s00018-012-1006-5 Document Type: Review |
Times cited : (22)
|
References (4)
|